"A total of 78 patients with similar demographic and disease characteristics were enrolled.
There was a significant reduction in ICU admissions (2 out of 39 vs. 11 out of 39, P=0.006),
intubation (1 out of 39 vs. 9 out of 39, P=0.007) and death (0 vs. 5, P=0.027) in the bromhexine
treated group compared to the standard group. No patients were withdrawn from the study because
of adverse effects."